Extracorporeal Life-support for Out-of-hospital Cardiac Arrest: A Nationwide Multicenter Study

Daun Jeong1, Gun Tak Lee1, Jong Eun Park1

  • 1Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Shock (Augusta, Ga.)
|March 10, 2022
PubMed

Insights

Extracorporeal life support (ECLS) did not improve overall outcomes for out-of-hospital cardiac arrest (OHCA) patients compared to conventional cardiopulmonary resuscitation (CCPR). ECLS may benefit specific high-risk subgroups, warranting further investigation.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Critical Care Medicine

Background:

  • Extracorporeal life support (ECLS) shows potential for out-of-hospital cardiac arrest (OHCA), but guidelines lack strong endorsement.
  • Conventional cardiopulmonary resuscitation (CCPR) is the standard, yet ECLS offers an alternative support mechanism.

Purpose of the Study:

  • To compare the clinical effectiveness of ECLS versus CCPR in OHCA patients.
  • To identify specific patient subgroups who might benefit most from ECLS.

Main Methods:

  • A multicenter registry (KoCARC) in South Korea collected OHCA data from 2015-2020.
  • Propensity score matching adjusted for baseline differences between ECLS and CCPR groups.
  • Restricted mean survival time (RMST) analyzed 30-day neurologically favorable survival.

Main Results:

  • Overall, ECLS (2.2% of 12,006 patients) did not significantly improve 30-day neurologically favorable survival compared to CCPR in propensity-matched pairs (RMST difference 0.4 days, P=0.67).
  • However, subgroup analysis indicated ECLS benefit in patients with nonshockable rhythm or CPR duration ≥20 minutes (RMST difference 2.7 days, P=0.015).
  • No significant benefit was observed in patients without these specific high-risk features.

Conclusions:

  • Real-world data suggests ECLS does not offer superior overall clinical outcomes for OHCA compared to CCPR.
  • The clinical utility of ECLS for OHCA appears confined to a select group of high-risk patients, particularly those with prolonged CPR or nonshockable rhythms.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
97
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
101
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
116